【结 构 式】 |
【药物名称】Pyraoncozine, NSC-D-364834, C-8412843, NSC-364834-D 【化学名称】3-(2-Chloroethyl)-3,4-dihydro-4-oxopyrazolo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide 【CA登记号】90521-23-6 【 分 子 式 】C7H7ClN6O2 【 分 子 量 】242.62584 |
【开发单位】Pfizer (Originator) 【药理作用】ONCOLYTIC DRUGS |
合成路线1
The pyrazolo[5,1-d]-1,2,3,5-tetrazine ring is synthesized according to the general method of Ege and Gilbert by the condensation of 3-diazopyrazole-4-carboxamide (I) with 2-chloroethyl isocyanate (II) in ethyl acetate at room temperature, followed by heating the reaction mixture at 50-60 C. The product may be purified through a silica gel column using ethyl acetate as the eluent. In contrast to the preparation of mitozolomide, the entire operation, including the preparation of the starting 3-diazo derivative, can be conducted under ordinary laboratory illumination. The dry product is stable under light even after 6 months.
【1】 Zolopa, A.R.; Whitcomb, J.M.; Hughes, M.D.; Katzenstein, D.A.; Winters, M.S.; Shafer, R.W.; Bates, M.; Shulman, N.S.; Hellmann, N.S.; J Pharm Sci 1968, 57, 2, 1044-1045. |
【2】 Roberts, M.S.; Smith, K.J.; Tetrahedron Lett 1979, 113, 4, 4235-4256. |
【3】 Cheng, C.C. (Pfizer Inc.); 3-(Haloethyl)-4-oxopyrazolo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide compounds. JP 60011489; US 4504475 . |
【4】 Zee-Cheng, R.K.-Y.; Cheng, C.C.; Pyraoncozine. Drugs Fut 1986, 11, 2, 121. |